Connect Biopharma Holdings Ltd (CNTB NASDAQ) stock market data APIs
$2.2075
0.02(0.9%)
as of July 21, 2026
Try our APIs with
free plan!
Connect Biopharma Holdings Ltd Financial Data Overview
Price chart is built with
Anychart
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Prev. Close
2.2075
Open
2.2269
High
2.2368
Low
2.1443
52 wk Range
1.23-3.82
Market Cap
139 M
Shares Outstanding
62 964 K
Revenue
233 K
EPS
-0.2695
Beta
-0.183
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Connect Biopharma Holdings Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Connect Biopharma Holdings Ltd data using free add-ons & libraries
Get Connect Biopharma Holdings Ltd Fundamental Data
Connect Biopharma Holdings Ltd Fundamental data includes:
- Net Revenue: 233 K
- EBITDA: -65 539 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Connect Biopharma Holdings Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -0.2825
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Connect Biopharma Holdings Ltd News
New
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key ...
Pre-Market Movers: TNON, ADTX, LNAI See Sharp Moves
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Pre-market movers give traders an early read on momentum, sentiment, and potential volatility for the trading day....
Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course
(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven...
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on trans...
Get Connect Biopharma Holdings Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
